Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Immunology and Microbiology March 2025

An Approach to Predict Intraocular Diseases by Machine Learning Based on Vitreous Humor Immune Mediator Profile

PDF

Risa Sugawara; Yoshihiko Usui; Akira Saito; Naoya Nezu; Hiroyuki Komatsu; Kinya Tsubota; Masaki Asakage; Naoyuki Yamakawa; Yoshihiro Wakabayashi; Masahiro Sugimoto; Masahiko Kuroda; Hiroshi Goto
TAGS: biological response modifiers, immune mediator, machine learning, vitreous body
Invest. Ophthalmol. Vis. Sci.. 2025; 66(3):38. https://doi.org/10.1167/iovs.66.3.38

ARVO Annual Meeting Abstract July 2019

Outcome of vitrectomy for retinal hemangioma

Kazuhiko Umazume; Yoshihiro Wakabayashi; Yoshihiko Usui; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3549.

ARVO Annual Meeting Abstract July 2018

Preoperative OCT images in macular-off rhegmatogenous retinal detachment

Kazuhiko Umazume; Yoshihiko Usui; Yoshihiro Wakabayashi; Masahiko Shimura; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4235.

ARVO Annual Meeting Abstract June 2017

Analysis of IL-10 in the intraocular fluids of patients with infectious uveitis

Ryosuke Matsushima; Yoshihiko Usui; Takeshi Kezuka; Kinya Tsubota; Akihiko Umazume; Naoyuki Yamakawa; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2180.

ARVO Annual Meeting Abstract September 2016

Inverted internal limiting membrane flap technique for macular hole retinal detachment.

Ryo Baba; Yoshihiro Wakabayashi; Kazuhiko Umazume; Daisuke Muramatsu; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1041.

ARVO Annual Meeting Abstract June 2015

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Liliana P Paris; Caroline H. Johnson; Edith Aguilar; Daniel Feitelberg; Yoshihiko Usui; Kinya Tsubota; Shunichiro Ueda; Yoshihiro Wakabayashi; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5203.

ARVO Annual Meeting Abstract April 2014

Scleral Buckling and Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment with inferior retinal tears

Kazuhiko Umazume; Hiromichi Yagi; Yoshihiro Wakabayashi; Jun Suzuki; Keisuke Kimura; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1085.

ARVO Annual Meeting Abstract April 2014

Angiogenin is a potent modulator of neovascularization and inflammation that is upregulated in various human retinal diseases

Carli M Wittgrove; Liliana P Paris; Yoshihiko Usui; Yoshihiro Wakabayashi; Edith Aguilar; Daniel Feitelberg; Peter D Westenskow; Leah C Byrne; John Gerard Flannery; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2242.

ARVO Annual Meeting Abstract April 2014

Cone Photoreceptors Can Generate the Potent Neurotrophic and Pro-angiogenic Fatty Acid Amide Erucamide

Peter D Westenskow; Toshihide Kurihara; Yoshihiko Usui; Stephen Bravo; Junhua Wang; Leah C Byrne; Yoshihiro Wakabayashi; John Gerard Flannery; Gary Suizdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5753.

Clinical and Epidemiologic Research October 2013

Axial Length as a Factor Associated With Visual Outcome After Vitrectomy for Diabetic Macular Edema

PDF

Yoshihiro Wakabayashi; Keisuke Kimura; Daisuke Muramatsu; Yoshihiko Usui; Kazuhiko Umazume; Jun Suzuki; Hiroshi Goto
TAGS: diabetic macular edema, eye, postoperative care, surgical procedures, operative, visual acuity, vitrectomy, diabetic retinopathy, edema
Invest. Ophthalmol. Vis. Sci.. 2013; 54(10):6834-6840. https://doi.org/10.1167/iovs.13-12519

ARVO Annual Meeting Abstract June 2013

Significance of measuring immune mediators for differentiating malignant from benign pigmented intraocular tumors

Yoshihiko Usui; Shunichiro Ueda; Yoko Okunuki; Kinya Tsubota; Kazuki Tajima; Takeshi Kezuka; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):169.

ARVO Annual Meeting Abstract June 2013

Effectiveness of prophylactic intravitreal bevacizumab injection in preventing complications after vitrectomy for proliferative diabetic retinopathy

Kinya Tsubota; Yoshihiro Wakabayashi; Shunichiro Ueda; Yoshihiko Usui; Jun Suzuki; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):198.

ARVO Annual Meeting Abstract June 2013

Outer retinal edema as a risk factor for poor visual outcome after bevacizumab therapy for macular edema with branch retinal vein occlusion

Daisuke Muramatsu; Maki Mishima; Yoshihiro Wakabayashi; Takuya Iwasaki; Shigemitsu Ishii; Setsuko Kawakami; Keisuke Kimura; Sayaka Gondo; Kazuhiko Umazume; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2829.

ARVO Annual Meeting Abstract June 2013

Intraocular fluid levels of immune mediators in retinal detachment

Shunichiro Ueda; Yoshihiko Usui; Yoko Okunuki; Takeshi Kezuka; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2858.

Clinical and Epidemiologic Research September 2012

Intraocular VEGF Level as a Risk Factor for Postoperative Complications after Vitrectomy for Proliferative Diabetic Retinopathy

PDF

Yoshihiro Wakabayashi; Yoshihiko Usui; Yoko Okunuki; Shunichiro Ueda; Keisuke Kimura; Daisuke Muramatsu; Takeshi Kezuka; Hiroshi Goto
TAGS: postoperative complications, risk factors, vascular endothelial growth factor a, vitrectomy, proliferative diabetic retinopathy, surgical procedures, operative, vitreous body
Invest. Ophthalmol. Vis. Sci.. 2012; 53(10):6403-6410. https://doi.org/10.1167/iovs.12-10367

Anatomy and Pathology/Oncology August 2012

Immune Mediators in Vitreous Fluids from Patients with Vitreoretinal B-Cell Lymphoma

PDF

Yoshihiko Usui; Yoshihiro Wakabayashi; Yoko Okunuki; Keisuke Kimura; Kazuki Tajima; Ryusaku Matsuda; Shunichiro Ueda; Juan Ma; Takeshi Nagai; Hideki Mori; Takeshi Kezuka; Toshitaka Nagao; Hiroshi Goto
TAGS: b-cell lymphomas, body fluid, immune mediator, vitreous body, biological response modifiers
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5395-5402. https://doi.org/10.1167/iovs.11-8719

Includes: Supplemental Content

ARVO Annual Meeting Abstract March 2012

Immune Mediators In Vitreous Fluids From Patients With Vitreoretinal B Cell Lymphoma

Yoshihiko Usui; Yoshihiro Wakabayashi; Yoko Okunuki; Hideki Mori; Takeshi Kezuka; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5471.

ARVO Annual Meeting Abstract March 2012

Correlation Of Complement Fragment C5a With Inflammatory Cytokines In The Vitreous Of Patients With Proliferative Diabetic Retinopathy

Daisuke Muramatsu; Yoshihiro Wakabayashi; Yoshihiko Usui; Yoko Okunuki; Takeshi Kezuka; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2422.

ARVO Annual Meeting Abstract April 2011

The role of CD14/sCD14 Costimulatory Pathway in Diabetic Retinopathy

Kazuhiko Umazume; Yoshihiko Usui; Yoko Okunuki; Takeshi Kezuka; Yoshihiro Wakabayashi; Hiroshi Goto

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1000.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

An Approach to Predict Intraocular Diseases by Machine Learning Based on Vitreous Humor Immune Mediator Profile

Outcome of vitrectomy for retinal hemangioma

Preoperative OCT images in macular-off rhegmatogenous retinal detachment

Analysis of IL-10 in the intraocular fluids of patients with infectious uveitis

Inverted internal limiting membrane flap technique for macular hole retinal detachment.

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Scleral Buckling and Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment with inferior retinal tears

Angiogenin is a potent modulator of neovascularization and inflammation that is upregulated in various human retinal diseases

Cone Photoreceptors Can Generate the Potent Neurotrophic and Pro-angiogenic Fatty Acid Amide Erucamide

Axial Length as a Factor Associated With Visual Outcome After Vitrectomy for Diabetic Macular Edema

Significance of measuring immune mediators for differentiating malignant from benign pigmented intraocular tumors

Effectiveness of prophylactic intravitreal bevacizumab injection in preventing complications after vitrectomy for proliferative diabetic retinopathy

Outer retinal edema as a risk factor for poor visual outcome after bevacizumab therapy for macular edema with branch retinal vein occlusion

Intraocular fluid levels of immune mediators in retinal detachment

Intraocular VEGF Level as a Risk Factor for Postoperative Complications after Vitrectomy for Proliferative Diabetic Retinopathy

Immune Mediators in Vitreous Fluids from Patients with Vitreoretinal B-Cell Lymphoma

Immune Mediators In Vitreous Fluids From Patients With Vitreoretinal B Cell Lymphoma

Correlation Of Complement Fragment C5a With Inflammatory Cytokines In The Vitreous Of Patients With Proliferative Diabetic Retinopathy

The role of CD14/sCD14 Costimulatory Pathway in Diabetic Retinopathy

To View More...

You must be signed into an individual account to use this feature.